Acetyl-TP73 (K327) Antibody

What is Acetyl-TP73 (K327) Antibody and What Does It Specifically Detect?

Acetyl-TP73 (K327) antibody is a polyclonal antibody raised in rabbits that specifically detects endogenous levels of the p73 protein only when acetylated at lysine 327 (K327) . This antibody was developed against a synthesized acetyl-peptide derived from human p73 around the acetylation site of Lys327, specifically targeting the amino acid region 291-340 .

The antibody recognizes p73, also known as tumor protein p73, which functions as a transcription factor involved in cellular responses to stress and development. As a member of the p53 family, p73 participates in the apoptotic response to DNA damage . The acetylation of K327 represents a specific post-translational modification that can regulate p73's function, particularly its transcriptional activity and protein-protein interactions.

How Does TP73 Differ from p53, and What Are Its Primary Biological Functions?

TP73 is a member of the p53 family of transcription factors, sharing structural and functional similarities with p53 while maintaining distinct biological roles . Unlike p53, TP73 is expressed as multiple isoforms through alternative promoter usage (TAp73 and ΔNp73) and alternative splicing at the C-terminus (α-η) .

The primary biological functions of TP73 include:

• Participation in apoptotic responses to DNA damage, with TAp73 isoforms being pro-apoptotic while ΔNp73 isoforms are anti-apoptotic

• Potential tumor suppression, particularly through the TAp73α isoform which is predominantly expressed in normal cells

• Neuronal development, with ΔNp73 being primarily expressed in and necessary for neuronal cells

• Regulation of gene expression, including activation of FOXJ1 expression

Interestingly, while TAp73α functions as a tumor suppressor, altered expression patterns of TAp73 C-terminal isoforms are frequently observed in human cancers, suggesting isoform-specific roles in tumorigenesis .

What Are the Optimal Applications and Experimental Conditions for Using Acetyl-TP73 (K327) Antibody?

The Acetyl-TP73 (K327) antibody has been validated and optimized for two primary applications:

• Western Blot (WB): The recommended dilution range is 1:500-1:2000 . Optimal results have been achieved using Jurkat cells, with secondary antibody diluted at 1:20000 . For detection of endogenous levels of acetylated p73, researchers should consider using positive controls where p73 acetylation is induced, such as DNA damage-responsive cell lines.

• ELISA: The recommended dilution is 1:20000 . This high dilution reflects the antibody's sensitivity in this application.

For both applications, the antibody shows cross-reactivity with human, mouse, and rat samples , making it versatile for comparative studies across these species.

Experimental conditions to consider:

• Buffer: The antibody is provided in liquid PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide

• Storage: Store at -20°C or -80°C, and avoid repeated freeze-thaw cycles

• Sample preparation: For optimal detection of acetylated p73, consider treatments that induce acetylation or inhibit deacetylation

What Are the Various Isoforms of TP73 and How Do They Impact Antibody Selection and Experimental Design?

TP73 is expressed as multiple isoforms through two key mechanisms:

• N-terminal variations: TAp73 (with transactivation domain) and ΔNp73 (lacking transactivation domain)

• C-terminal variations: Multiple isoforms (α, β, γ, δ, ε, ζ, η) generated by alternative splicing of exons 11-13

These isoforms have significant implications for experimental design:

When using Acetyl-TP73 (K327) antibody, researchers should consider:

• The antibody detects acetylation at K327 across isoforms

• The predominant isoform in most tissues is p73α, which may influence signal strength

• Expression levels vary dramatically between isoforms, with p73γ almost undetectable under normal conditions

• Isoform switching (e.g., from p73α to p73γ) occurs in cancer contexts, potentially altering antibody detection patterns

For comprehensive analysis, researchers may need to use multiple antibodies targeting different domains or post-translational modifications.

How Can Researchers Validate the Specificity of Acetyl-TP73 (K327) Antibody in Their Experimental Systems?

Validation of Acetyl-TP73 (K327) antibody specificity is crucial for reliable experimental outcomes. Recommended validation approaches include:

• Positive and negative controls:

  • Use cell lines with known p73 expression (e.g., Jurkat cells as shown in the antibody validation data)

  • Compare acetylation signals before and after treatments that induce p73 acetylation (e.g., DNA damage inducers)

  • Include p73-knockout cells or tissue as negative controls

• Peptide competition assay:

  • Pre-incubate the antibody with the immunizing peptide (acetylated peptide from p73 around K327)

  • A specific antibody will show reduced or eliminated signal when pre-incubated with the immunizing peptide

• Isoform-specific validation:

  • Since p73 exists in multiple isoforms, use cells expressing predominantly one isoform

  • Compare with cells where isoform switching has occurred (e.g., E11-knockout cells show p73α to p73γ switch)

• Cross-technique validation:

  • Confirm acetylation status using multiple techniques (e.g., mass spectrometry)

  • Use immunoprecipitation followed by Western blotting with another p73 antibody

• Species cross-reactivity:

  • When transitioning between human, mouse, and rat samples, perform comparative validation to ensure consistent specificity

What Are Common Technical Challenges When Using Acetyl-TP73 (K327) Antibody and How Can They Be Addressed?

Researchers often encounter several technical challenges when working with Acetyl-TP73 (K327) antibody:

• Low signal intensity:

  • Challenge: Acetylated p73 may be present at low levels in many cell types

  • Solution: Enrich the target protein via immunoprecipitation before Western blotting

  • Solution: Use treatments that enhance p73 acetylation (HDAC inhibitors, DNA damaging agents)

  • Solution: Optimize antibody concentration (start with 1:500 dilution for Western blot)

• Background or non-specific signals:

  • Challenge: Polyclonal antibodies may produce background

  • Solution: Increase blocking time/concentration (5% BSA or milk)

  • Solution: Optimize washing steps (increased duration/frequency)

  • Solution: Use secondary antibody at recommended dilution (1:20000)

• Isoform complexity:

  • Challenge: Multiple p73 isoforms with different molecular weights complicate band interpretation

  • Solution: Use positive controls with known isoform expression

  • Solution: Include parallel blots with isoform-specific antibodies for comparison

  • Solution: Consider the context-specific isoform expression patterns (e.g., p73γ increases in some cancer contexts)

• Species-specific variations:

  • Challenge: Antibody may perform differently across human, mouse, and rat samples

  • Solution: Adjust protein loading and antibody concentration for each species

  • Solution: Validate with species-specific positive controls

• Storage and stability issues:

  • Challenge: Antibody activity may decrease over time or with freeze-thaw cycles

  • Solution: Aliquot antibody upon receipt to avoid repeated freeze-thaw cycles

  • Solution: Store at recommended temperature (-20°C or -80°C)

How Does TP73 Acetylation at K327 Influence Its Functional Activities and Interactions?

Acetylation at K327 represents a critical post-translational modification that modulates TP73's function in several ways:

• Transcriptional activity regulation:

  • Acetylation at K327 likely influences p73's ability to bind DNA and activate target genes

  • This modification may alter the recruitment of transcriptional cofactors to p73-regulated promoters

• Protein stability and turnover:

  • Post-translational modifications including acetylation can affect protein stability

  • p73 undergoes proteasomal degradation, which can be influenced by its modification state

  • The search results indicate p73 can be polyubiquitinated by RCHY1/PIRH2, leading to proteasomal degradation

• Interplay with other modifications:

  • p73 undergoes multiple post-translational modifications, including:

    • Phosphorylation by PLK1 and PLK3, which inhibits transcriptional activity and pro-apoptotic function

    • Sumoylation of isoform alpha (but not beta) on Lys-627, potentiating proteasomal degradation

  • Acetylation may interact with these modifications in complex regulatory networks

• Isoform-specific effects:

  • The significance of K327 acetylation may vary between p73 isoforms

  • The unique C-terminal domain of p73γ (76 amino acids) may interact differently with acetylation at K327 compared to p73α

• Cellular context dependency:

  • The functional impact of K327 acetylation likely depends on cell type and physiological conditions

  • In cancer contexts, where isoform switching occurs (e.g., p73α to p73γ), the significance of K327 acetylation may change

How Can Acetyl-TP73 (K327) Antibody Be Used to Investigate the Role of TP73 in Cancer Research?

Acetyl-TP73 (K327) antibody offers several methodological approaches for cancer research:

• Isoform switching analysis:

  • The antibody can help detect changes in p73 acetylation patterns during isoform switching events

  • Research has shown that p73α to p73γ switching occurs frequently in human prostate cancers and dog lymphomas

  • This switching can be monitored through Western blot analysis, comparing acetylation signals across cancer types

• Tumor-specific acetylation patterns:

  • Comparing acetylation levels between normal and tumor tissues can reveal cancer-specific modifications

  • Data suggests that alterations in TAp73 are frequent in human cancers, potentially involving changes in acetylation status

• Mechanistic studies of p73-mediated oncogenesis:

  • The antibody can be used to correlate p73 acetylation with oncogenic activities

  • Studies show that p73γ (detectable with appropriate antibodies) exerts oncogenic activities by promoting cell proliferation and migration

  • Experiments can be designed to manipulate acetylation and assess downstream effects on these oncogenic functions

• Pathway analysis:

  • Acetyl-TP73 (K327) antibody can help investigate the relationship between p73 acetylation and cancer-relevant pathways

  • For example, the p73γ-Leptin pathway promotes tumorigenesis and alters lipid metabolism

  • Researchers can design experiments that correlate acetylation status with Leptin expression and downstream effects

• Therapeutic response monitoring:

  • Changes in p73 acetylation following treatment with anti-cancer agents can provide insights into therapeutic mechanisms

  • The antibody can be used in time-course experiments to track acetylation dynamics during treatment

What Methodological Approaches Can Be Used to Study Dynamic Changes in TP73 Acetylation?

Studying the dynamic nature of p73 acetylation requires sophisticated methodological approaches:

• Time-course experiments:

  • Design experiments with multiple time points after stimulus application

  • Apply treatments known to affect p73 activity (e.g., DNA damage inducers, HDAC inhibitors)

  • Use Acetyl-TP73 (K327) antibody in Western blot analysis (1:500-1:2000 dilution) at each time point

• Combined detection of total and acetylated p73:

  • Run parallel Western blots using Acetyl-TP73 (K327) antibody and a total p73 antibody

  • Calculate the ratio of acetylated to total p73 to normalize for expression changes

  • This approach distinguishes between changes in acetylation versus changes in protein abundance

• Live-cell imaging approaches:

  • Develop fluorescent reporter systems for p73 acetylation

  • This might involve FRET-based sensors where donor and acceptor fluorophores are brought together upon acetylation

  • Such systems would require validation using the Acetyl-TP73 (K327) antibody

• Cell fractionation studies:

  • Separate nuclear and cytoplasmic fractions before Western blot analysis

  • Determine if acetylation affects p73 subcellular localization

  • Use appropriate fraction markers (e.g., Lamin B for nuclear fraction) as controls

• Mass spectrometry validation:

  • Immunoprecipitate p73 using a total p73 antibody

  • Analyze by mass spectrometry to quantify acetylation at K327 and other sites

  • Compare results with Western blot data using Acetyl-TP73 (K327) antibody

How Can Researchers Interpret Complex or Contradictory Data When Studying TP73 Acetylation?

Interpreting complex data regarding p73 acetylation requires careful consideration of several factors:

• Isoform complexity:

  • Consider which p73 isoforms are present in your experimental system

  • Remember that p73α is typically the predominant isoform in normal cells, while isoform switching (e.g., to p73γ) occurs in cancer contexts

  • Different isoforms may show different patterns of acetylation and function

• Context-dependent effects:

  • The same modification may have different consequences in different cell types or conditions

  • Compare results across multiple cell lines or tissue types

  • Consider the cellular stress context, as p73 functions in stress response pathways

• Interaction with other modifications:

  • Acetylation at K327 may interact with other post-translational modifications

  • p73 undergoes multiple modifications including phosphorylation by PLK1/PLK3 and sumoylation

  • These interactions may explain seemingly contradictory results

• Methodological considerations:

  • Different techniques (Western blot, mass spectrometry, functional assays) may yield different results

  • Ensure proper controls for each technique

  • Consider antibody specificity limitations when interpreting data

• Analytical framework for contradictory results:

  Observation	Possible Explanation	Verification Approach
  Acetylation increases but function decreases	Other modifications counteract acetylation effects	Map all modifications by mass spectrometry
  Different results in different cell lines	Cell-specific cofactors influence acetylation effects	Compare protein interaction partners across cell lines
  Acute vs. chronic effects differ	Feedback mechanisms alter long-term responses	Design both short and long time-course experiments
  In vitro vs. in vivo discrepancies	Tissue microenvironment influences modification patterns	Validate findings in animal models

What Advanced Experimental Approaches Can Be Combined with Acetyl-TP73 (K327) Antibody for Comprehensive TP73 Research?

Integrating Acetyl-TP73 (K327) antibody into advanced experimental approaches enables more comprehensive understanding of p73 biology:

• ChIP-seq analysis:

  • Use Acetyl-TP73 (K327) antibody in chromatin immunoprecipitation followed by sequencing

  • Identify genomic binding sites specifically occupied by acetylated p73

  • Compare acetylated p73 binding with non-acetylated p73 to determine acetylation-specific target genes

• Proximity ligation assay (PLA):

  • Combine Acetyl-TP73 (K327) antibody with antibodies against potential interaction partners

  • Visualize and quantify protein interactions specific to acetylated p73

  • This approach can reveal acetylation-dependent protein complexes

• CRISPR-based functional screening:

  • Use CRISPR to manipulate enzymes involved in p73 acetylation/deacetylation

  • Apply Acetyl-TP73 (K327) antibody to monitor changes in acetylation status

  • Correlate with phenotypic outcomes to determine functional significance

  • Similar approaches have been used to study p73 isoform switching through E11 deletion

• Single-cell analysis:

  • Apply Acetyl-TP73 (K327) antibody in immunofluorescence or flow cytometry

  • Analyze cell-to-cell variability in p73 acetylation

  • Correlate with single-cell transcriptomics to identify acetylation-responsive gene signatures

• In vivo models:

  • Generate mouse models with mutations affecting p73 acetylation

  • Use Acetyl-TP73 (K327) antibody to validate acetylation status changes

  • Examine phenotypic consequences, potentially including cancer susceptibility

  • The search results describe E11-deficient mice that are more prone to obesity and B-cell lymphomas

How Does TP73 Acetylation Contribute to Its Role in Specific Biological Processes Beyond Cancer?

While cancer research is prominent in TP73 studies, acetylation of p73 at K327 likely influences multiple biological processes:

• Neuronal development and function:

  • ΔNp73 is primarily expressed in neuronal cells and necessary for neuronal development

  • Acetylation may regulate ΔNp73's neurodevelopmental functions

  • Researchers can use Acetyl-TP73 (K327) antibody to examine acetylation patterns in neuronal tissues

• Metabolism and obesity:

  • E11-deficient mice (which predominantly express p73γ instead of p73α) are more prone to obesity

  • The p73γ-Leptin pathway alters lipid metabolism

  • Acetylation at K327 may influence these metabolic functions of p73

  • Experiments can correlate acetylation status with metabolic parameters and Leptin expression

• Inflammation and immune responses:

  • E11-deficient mice phenocopy Trp73-deficient mice with chronic inflammation

  • Acetylation may modulate p73's role in inflammatory processes

  • Researchers can examine acetylation patterns in immune cells under inflammatory conditions

• Fertility and reproduction:

  • Trp73-deficient and E11-deficient mice exhibit infertility

  • Acetylation could influence p73's reproductive functions

  • The antibody can be used to study acetylation patterns in reproductive tissues

• Aging and lifespan:

  • E11-deficient mice have shortened lifespans

  • p73 acetylation patterns may change with age

  • Longitudinal studies using the antibody could reveal age-dependent changes in acetylation

By investigating these diverse biological contexts, researchers can gain comprehensive understanding of how p73 acetylation contributes to normal physiology and disease beyond cancer.